Whitehawk Therapeutics Inc (WHWK) Stock Price, Quote & News

Company Profile

Whitehawk Therapeutics, Inc., a clinical-stage oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides three next generation antibody drug conjugates (ADC) portfolio to treat cancer. The company was formerly known as Aadi Bioscience, Inc. and changed its name to Whitehawk Therapeutics, Inc. in August 2021. Whitehawk Therapeutics, Inc. was incorporated in 2007 and is headquartered in Morristown, New Jersey.

Industry: Biotechnology

Sector: Healthcare

Phone: 551-321-2234

Website: ir.whitehawktx.com

Address:

2 Headquarters Plaza, East Building 11th Floor, Morristown, United States

MikiTrader Jun. 7 at 9:14 PM

$WHWK Maybe it's worth taking a break and coming back with a fresh perspective.

0 · Reply

HectorNumba9 Jun. 3 at 4:25 PM

$WHWK This i was right. This u have plenty of time to rack up. Gonna go up like a slow train/savings account. Big players are here till least 2028-2029. Remember stocks there's always that chance to get screwed

0 · Reply

AlertsAndNews May. 31 at 10:37 PM

$WHWK Whitehawk Therapeutics Presents Real‑World Analysis Confirming SEZ6 as a Highly Expressed, Clinically Relevant Target for SCLC and Other Neuroendocrine Tumors at ASCO 2026

0 · Reply

smartmoney43 May. 26 at 3:55 PM

$WHWK 😍😍

0 · Reply

mikesterz7 May. 22 at 3:07 AM

$WHWK Whitehawk said it has secured rights from Hangzhou DAC to use the CPT113 linker-payload technology in up to five additional internally developed programs.

0 · Reply

StocktwitsNews May. 22 at 12:38 AM

WHWK Stock Edges Up After Hours: Firm Boosts Pipeline Of Cancer Drugs On The Heels Of Capital Raise $WHWK $VTI $VXF https://stocktwits.com/news/equity/markets/whwk-stock-edges-up-after-hours-firm-boosts-pipeline-of-cancer-drugs/cZgbsJBRe8o

0 · Reply

focafoca99 May. 15 at 12:26 PM

$WHWK joined the 2026 Stifel Virtual Targeted Oncology Forum, with CEO Dave Lennon speaking in a fireside chat.

0 · Reply

smartmoney43 May. 14 at 2:47 PM

$WHWK 😍😍😍

0 · Reply

brallt May. 14 at 1:39 PM

$WHWK

0 · Reply

brallt May. 13 at 9:11 PM

$WHWK can you imagine a 100k slap/ cover. I see you 12$ ask.

0 · Reply

Whitehawk Therapeutics Transcript: Jefferies Global Healthcare Conference 2026

2026-05-31T21:35:57.000Z - 8 days ago

Whitehawk Therapeutics presents real-world analysis on SEZ6

May 30, 2026, 2:30 PM EDT - 9 days ago

Whitehawk Therapeutics Presents Real‑World Analysis Confirming SEZ6 as a Highly Expressed, Clinically Relevant Target for SCLC and Other Neuroendocrine Tumors at ASCO 2026

May 29, 2026, 8:00 AM EDT - 10 days ago

Whitehawk Therapeutics Registration statement: Registration filing

May 28, 2026, 4:05 PM EDT - 11 days ago

Whitehawk Therapeutics to Present at the Jefferies 2026 Global Healthcare Conference

May 27, 2026, 11:00 AM EDT - 12 days ago

Whitehawk Therapeutics Transcript: 7th Annual Oncology Innovation Summit: Insights for ASCO & EHA

May 21, 2026, 5:05 PM EDT - 18 days ago

Whitehawk Therapeutics Expands ADC Pipeline with New Option Agreement for Use of CPT113 Linker-Payload

May 20, 2026, 8:00 AM EDT - 19 days ago

Whitehawk Therapeutics to Participate in the TD Cowen 7th Annual Oncology Innovation Summit

May 19, 2026, 3:00 PM EDT - 20 days ago

Whitehawk Therapeutics Transcript: Stifel 2026 Targeted Oncology Virtual Forum

May 15, 2026, 8:00 AM EDT - 24 days ago

Whitehawk Therapeutics to Participate in 2026 Stifel Virtual Targeted Oncology Forum

2026-05-13T16:50:24.000Z - 26 days ago

Whitehawk Therapeutics announces $87.5M private placement

May 13, 2026, 8:00 AM EDT - 26 days ago

Whitehawk Therapeutics Announces $87.5M Private Placement Equity Financing

2026-05-08T15:52:53.000Z - 4 weeks ago

Whitehawk Therapeutics price target raised to $7 from $6 at Oppenheimer

2026-05-07T13:20:45.000Z - 4 weeks ago

Whitehawk Therapeutics reports Q1 EPS (32c), consensus (33c)

May 7, 2026, 9:00 AM EDT - 4 weeks ago

Whitehawk Therapeutics Earnings release: Q1 2026

May 7, 2026, 9:00 AM EDT - 4 weeks ago

Whitehawk Therapeutics Quarterly report: Q1 2026

May 7, 2026, 8:00 AM EDT - 4 weeks ago

Whitehawk Therapeutics Reports First Quarter 2026 Financial Results and Recent Highlights

May 7, 2026, 7:00 AM EDT - 4 weeks ago

Whitehawk Therapeutics Slides: Corporate presentation

Apr 28, 2026, 8:00 AM EDT - 5 weeks ago

Whitehawk Therapeutics Proxy statement: Proxy filing

Apr 28, 2026, 8:00 AM EDT - 5 weeks ago

Whitehawk Therapeutics Proxy statement: Proxy filing

2026-04-20T00:45:07.000Z - 7 weeks ago

Whitehawk announces presentation of new preclinical data across ADC portfolio

Apr 19, 2026, 6:00 PM EDT - 7 weeks ago

Whitehawk Therapeutics Presents Comprehensive Preclinical Data Highlighting its Next-Generation ADC Portfolio at the AACR 2026

Apr 16, 2026, 4:05 PM EDT - 7 weeks ago

Whitehawk Therapeutics to Participate in Jones Trading Post-AACR Fireside Chat Series

2026-04-16T19:41:37.000Z - 7 weeks ago

Whitehawk Therapeutics management to meet with Oppenheimer

2026-04-16T09:25:48.000Z - 7 weeks ago

Whitehawk Therapeutics initiated with an Outperform at Citizens

2026-04-10T11:13:42.000Z - 2 months ago

Whitehawk Therapeutics presents analysis of MUC16 at SGO

Apr 10, 2026, 7:00 AM EDT - 2 months ago

Whitehawk Therapeutics Presents Real-World Analysis Confirming MUC16 as a Highly Expressed, Clinically Relevant Target for Gynecologic Cancers at SGO 2026

Mar 17, 2026, 4:30 PM EDT - 2 months ago

Whitehawk Therapeutics to Highlight its Next-Generation ADC Portfolio at the American Association for Cancer Research (AACR) Annual Meeting 2026

2026-03-12T12:07:42.000Z - 3 months ago

Whitehawk Therapeutics reports Q4 EPS (34c) vs. (67c) last year

Mar 12, 2026, 8:00 AM EDT - 3 months ago

Whitehawk Therapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Highlights

Mar 12, 2026, 8:00 AM EDT - 3 months ago

Whitehawk Therapeutics Annual report: Q4 2025

Mar 12, 2026, 8:00 AM EDT - 3 months ago

Whitehawk Therapeutics Earnings release: Q4 2025

Mar 10, 2026, 12:30 PM EDT - 3 months ago

Whitehawk Therapeutics Transcript: The Citizens Life Sciences Conference 2026

Mar 3, 2026, 10:30 AM EST - 3 months ago

Whitehawk Therapeutics Transcript: TD Cowen 46th Annual Health Care Conference

Feb 26, 2026, 8:00 AM EST - 3 months ago

Whitehawk Therapeutics to Participate in Upcoming Investor Conferences

Feb 25, 2026, 8:40 AM EST - 3 months ago

Whitehawk Therapeutics Transcript: Oppenheimer 36th Annual Healthcare Life Sciences Conference

Feb 18, 2026, 8:00 AM EST - 3 months ago

Whitehawk Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference

2026-02-05T14:40:51.000Z - 4 months ago

Whitehawk Therapeutics initiated with an Outperform at Oppenheimer

2026-01-08T13:11:16.000Z - 5 months ago

Whitehawk Therapeutics says FDA clears IND application for HWK-007

Jan 8, 2026, 8:00 AM EST - 5 months ago

Whitehawk Therapeutics Advances to Clinical Stage with IND Clearance for HWK-007 and Announces IND Submission for HWK-016

2025-12-22T17:05:25.000Z - 6 months ago

Whitehawk Therapeutics initiated with a Buy at JonesResearch

Dec 3, 2025, 12:30 PM EST - 6 months ago

Whitehawk Therapeutics Transcript: Piper Sandler 37th Annual Healthcare Conference

2025-12-01T13:15:59.000Z - 6 months ago

Whitehawk Therapeutics appoints Dugan as Chief Medical Officer

Dec 1, 2025, 8:00 AM EST - 6 months ago

Whitehawk Therapeutics Appoints Margaret Dugan, MD, as Chief Medical Officer

Nov 26, 2025, 8:00 AM EST - 6 months ago

Whitehawk Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference

Nov 18, 2025, 6:30 AM EST - 7 months ago

Whitehawk Therapeutics Transcript: Jefferies London Healthcare Conference 2025

Nov 11, 2025, 8:00 AM EST - 7 months ago

Whitehawk Therapeutics to Present at Jefferies Global Healthcare Conference in London

2025-11-06T13:11:09.000Z - 7 months ago

Whitehawk Therapeutics reports Q3 EPS (26c) vs. (46c) last year

Nov 6, 2025, 8:00 AM EST - 7 months ago

Whitehawk Therapeutics Reports Third Quarter 2025 Financial Results and Recent Highlights

Nov 6, 2025, 8:00 AM EST - 7 months ago

Whitehawk Therapeutics Quarterly report: Q3 2025

Nov 6, 2025, 8:00 AM EST - 7 months ago

Whitehawk Therapeutics Earnings release: Q3 2025

Oct 24, 2025, 12:30 PM EDT - 8 months ago

Whitehawk Therapeutics Presents Real-World Analysis Confirming PTK7 as a Broadly Expressed, Clinically Relevant Target Across Solid Tumors at AACR-NCI-EORTC

2025-10-16T12:35:51.000Z - 8 months ago

Tempus AI enters pact with Whitehawk Therapeutics to advance oncology research

TEM

Oct 16, 2025, 8:30 AM EDT - 8 months ago

Tempus Announces Collaboration with Whitehawk Therapeutics to Advance Biomarker-Driven Oncology Research

TEM

Sep 9, 2025, 3:30 PM EDT - 9 months ago

Whitehawk Therapeutics Transcript: H.C. Wainwright 27th Annual Global Investment Conference

Sep 8, 2025, 4:50 PM EDT - 9 months ago

Whitehawk Therapeutics Transcript: Morgan Stanley 23rd Annual Global Healthcare Conference

Aug 7, 2025, 8:30 AM EDT - 10 months ago

Whitehawk Therapeutics Quarterly report: Q2 2025

Aug 7, 2025, 8:30 AM EDT - 10 months ago

Whitehawk Therapeutics Earnings release: Q2 2025

Aug 7, 2025, 8:00 AM EDT - 10 months ago

Whitehawk Therapeutics Reports Second Quarter 2025 Financial Results and Recent Highlights

Aug 7, 2025, 7:00 AM EDT - 10 months ago

Whitehawk Therapeutics Slides: Corporate Presentation

Jul 22, 2025, 8:00 AM EDT - 11 months ago

Whitehawk Therapeutics to Participate in the BTIG Virtual Biotechnology Conference

Jun 26, 2025, 10:00 AM EDT - 1 year ago

Whitehawk Therapeutics Transcript: Fireside Chat

Jun 19, 2025, 8:00 AM EDT - 1 year ago

Whitehawk Therapeutics to Participate in H.C. Wainwright "HCW@Home" Series

Jun 4, 2025, 2:00 PM EDT - 1 year ago

Whitehawk Therapeutics Transcript: Jefferies Global Healthcare Conference 2025

May 28, 2025, 2:30 PM EDT - 1 year ago

Whitehawk Therapeutics Transcript: TD Cowen's 6th Annual Oncology Innovation Summit

May 28, 2025, 8:00 AM EDT - 1 year ago

Whitehawk Therapeutics to Present at the Jefferies 2025 Global Healthcare Conference

May 21, 2025, 8:00 AM EDT - 1 year ago

Whitehawk Therapeutics to Participate in the TD Cowen 6th Annual Oncology Innovation Summit

May 8, 2025, 4:05 PM EDT - 1 year ago

Whitehawk Reports First Quarter 2025 Financial Results and Recent Highlights

May 8, 2025, 4:00 PM EDT - 1 year ago

Whitehawk Therapeutics Quarterly report: Q1 2025

May 8, 2025, 4:00 PM EDT - 1 year ago

Whitehawk Therapeutics Earnings release: Q1 2025

May 8, 2025, 4:00 PM EDT - 1 year ago

Whitehawk Therapeutics Slides: Q1 2025

Apr 28, 2025, 8:00 AM EDT - 1 year ago

Whitehawk Therapeutics Proxy statement: Proxy Filing

Apr 28, 2025, 8:00 AM EDT - 1 year ago

Whitehawk Therapeutics Proxy statement: Proxy Filing

2025-03-31T21:35:08.000Z - 1 year ago

Whitehawk Therapeutics files to sell 41.67M shares of common stock for holders

Mar 31, 2025, 8:00 AM EDT - 1 year ago

Whitehawk Therapeutics Registration statement: Registration Filing

Mar 26, 2025, 8:00 AM EDT - 1 year ago

Whitehawk Therapeutics Completes Strategic Transformation with Successful Closing of Sale of Aadi Subsidiary to Kaken Pharmaceuticals

Mar 19, 2025, 8:30 AM EDT - 1 year ago

Whitehawk Therapeutics Earnings Call Transcript: Q4 2024

Mar 19, 2025, 8:30 AM EDT - 1 year ago

Whitehawk Therapeutics Annual report: Q4 2024

Mar 19, 2025, 8:30 AM EDT - 1 year ago

Whitehawk Therapeutics Earnings release: Q4 2024

Mar 18, 2025, 4:00 PM EDT - 1 year ago

Aadi Bioscience Relaunches as Whitehawk Therapeutics Marking Evolution into ADC Company

MikiTrader Jun. 7 at 9:14 PM

$WHWK Maybe it's worth taking a break and coming back with a fresh perspective.

0 · Reply

HectorNumba9 Jun. 3 at 4:25 PM

0 · Reply

AlertsAndNews May. 31 at 10:37 PM

$WHWK Whitehawk Therapeutics Presents Real‑World Analysis Confirming SEZ6 as a Highly Expressed, Clinically Relevant Target for SCLC and Other Neuroendocrine Tumors at ASCO 2026

0 · Reply

smartmoney43 May. 26 at 3:55 PM

$WHWK 😍😍

0 · Reply

mikesterz7 May. 22 at 3:07 AM

$WHWK Whitehawk said it has secured rights from Hangzhou DAC to use the CPT113 linker-payload technology in up to five additional internally developed programs.

0 · Reply

StocktwitsNews May. 22 at 12:38 AM

0 · Reply

focafoca99 May. 15 at 12:26 PM

$WHWK joined the 2026 Stifel Virtual Targeted Oncology Forum, with CEO Dave Lennon speaking in a fireside chat.

0 · Reply

smartmoney43 May. 14 at 2:47 PM

$WHWK 😍😍😍

0 · Reply

brallt May. 14 at 1:39 PM

$WHWK

0 · Reply

brallt May. 13 at 9:11 PM

$WHWK can you imagine a 100k slap/ cover. I see you 12$ ask.

0 · Reply

brallt May. 13 at 8:25 PM

$WHWK things get interesting over 5$. She could run hard if shorts start to cover.

0 · Reply

topstockalerts May. 13 at 8:05 PM

$WHWK that little breakout is holding better than expected.

0 · Reply

StockJelli May. 13 at 7:56 PM

Alerts today 👇👀 $SLS $WHWK $VNET $TDIC

0 · Reply

brallt May. 13 at 7:54 PM

$WHWK 😉

0 · Reply

LBTheEmcee May. 13 at 7:39 PM

$WHWK yup I quit trading mornings get trapped every time avg is 4.95 how the fck can it not get back there is beyond me

0 · Reply

LBTheEmcee May. 13 at 7:25 PM

$WHWK manipulation at its finest they swept stops scaring retail with a fake order block of 175k who bought up all the 4.70s and these crops still won’t let it break 5.00

0 · Reply

LBTheEmcee May. 13 at 7:19 PM

$WHWK all you fcking morons haven’t do is get it over 5 I’m sick of this man markets are so fcking corrupt

0 · Reply

brallt May. 13 at 7:16 PM

$WHWK Adding.

1 · Reply

LBTheEmcee May. 13 at 7:11 PM

$WHWK no one selling 187000 shares by the way don’t ppl know what spoofing is

0 · Reply

LBTheEmcee May. 13 at 7:10 PM

$WHWK fucking piece of shit man

0 · Reply

StockJelli May. 13 at 7:06 PM

It is now power hour. Here are the stocks we sent notifications out for so far: $WHWK $SLS $VNET

0 · Reply

LBTheEmcee May. 13 at 7:04 PM

$TDIC and here I am stuck in $WHWK cause fidelity wouldn’t let me trade this fucking jokes

0 · Reply

Market Cap	205.23M
Revenue (ttm)	7.15M
Net Income (ttm)	-20.60M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-288.11%
Debt to Equity Ratio	0.00

Volume	362,600
Avg Vol	334,132
Day's Range	N/A - N/A
Shares Out	49.45M
Stochastic %K	5%
Beta	0.77
Analysts	Sell
Price Target	$6.50